R&D Deal, PTV News: May 06, 2010

Episode Loading...

PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: R&D Deal, PTV News: May 06, 2010
Released on: May 06, 2010. © PharmaVentures Ltd
Visitors: You are watching a 1 minute preview.
Share/save this page:
Follow us:
  • Summary
  • Transcript
  • Company
Boehringer Ingelheim and Micromet collaborate on R&D and commercialisation of cancer therapy
Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.
Boehringer Ingelheim
Boehringer Ingelheim GmbH is a pharmaceutical company which concentrates on the development of human pharmaceuticals, biopharmaceuticals, chemicals, and animal health products. The Human Pharmaceuticals sector is the company's largest division, accounting for about 96% of sales. This includes prescription medicines and consumer healthcare products.
Micromet, Inc. is a biopharmaceutical company focused on the development and commercialisation of next-generation antibodies for the treatment of cancer.